Diagnosis of schizophrenia by integrated saccade scores and associations with psychiatric symptoms, and functioning

Jiahui Zhu,Li Zhou,Yuanyuan Zhou,Yunhan Lin,Yumei Cai,Jiayuan Wu,Chuan Shi
DOI: https://doi.org/10.1097/md.0000000000039935
IF: 1.6
2024-10-15
Medicine
Abstract:Schizophrenia with a variety of symptoms, including distinctive types of hallucinations, delusions, and unusual behaviors, as well as declines in cognitive and functioning. The global prevalence of schizophrenia is estimated to be 1%, but the economic burden of the disorder is increasing, [ 1 ] which underscores the seriousness of the disorder. Schizophrenia typically begins during adolescence or early adulthood, [ 2 , 3 ] and can be a life-long disease; however, there is evidence that early diagnosis can substantially improve clinical outcomes in psychiatric patients. [ 4 ] Numerous genetic, neurophysiologic, and neuroimaging studies [ 5 , 6 ] have implicated deficits in schizophrenia patients, but the pathological mechanism of the disease is still not completely understood and poses a challenge to diagnosis. [ 7 ] Exploring more objective and reliable biomarkers may address limitations in current clinical diagnostic methods has led to a rapidly growing interest in diagnostic biomarkers for schizophrenia. [ 8 ]
medicine, general & internal
What problem does this paper attempt to address?